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Abstract: It is known that patients with congestive heart failure have reduced ability to 
modulate heart rate in comparison with normal subjects. However, the characteristics of these 
changes is not well understood. This study therefore investigated the characteristic features of 
heart rate changes to assess how they differed between both groups. Fifty-two normal sinus 
rhythm subjects and 18 congestive heart failure patients from the PhysioNet database were 
studied. Nine common heart rate indices were studied: three time-domain indices (MEAN RR 
interval, standard deviation of successive RR SDNN, and square root of mean squared 
differences of successive RR RMSSD), three frequency-domain indices (normalized 
low-frequency power LFn, normalized high-frequency power HFn, and their ratio LF/HF), and 
three non-linear indices (vector length index VLI, vector angle index VAI and sample entropy 
SampEn). Two 5-min segments from every subject, neither of which had any ectopic beat, 
were analyzed. The statistical differences between the two clinical groups for the first and 
second segments, and their average were determined for all nine indices. Results showed that 
there was no significant difference between the two 5-min RR interval segments for any 
technique. All frequency-domain and non-linear indices, but only one time-domain index 
(SDNN), were significantly different between subject groups. However, some indices were 
much more sensitive to the clinical differences than others; with the best performing 
techniques, one non-linear index VLI and one time domain index SDNN, followed by all 
three frequency indices of LFn, HFn and LF/HF, and finally two of the other non-linear indices 
VAI and SampEn. A simple RBF SVM-based classification algorithm gave a good 
performance for classifying the CHF and NSR subjects. And the mean 𝑆𝑒, 𝑆𝑝 and 𝐴𝑐𝑐 of 
SVM classifier from 10 folds were 91.31%, 90.04% and 90.95% respectively. We have shown 
that there are characteristic differences in heart rate changes between congestive heart failure 
and normal sinus rhythm, suggesting characteristic rhythm differences. 
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1. Introduction 
Heart rate variability (HRV) analysis is a non-invasive method for assessing the function 
of the cardiovascular autonomic nervous system (ANS) [1; 2]. Depressed HRV has been used 
as a predictor of risk after acute myocardial infarction [3], and as an early warning sign of 
diabetic neuropathy [4]. In addition, low HRV has been observed in patients suffering from 
dilated cardiomyopathy [5], fetal distress conditions, and obstructive sleep apnea [6; 7], as 
well as congestive heart failure (CHF) [8-11]. CHF is a typical degeneration of the heart 
function featured by the reduced ability for the heart to pump blood efficiently [7]. It is a 
difficult condition to manage in clinical practice, and the mortality from CHF is high [12-16].  
For healthy subjects, it has been proven that the increased sympathetic and the decreased 
parasympathetic activity results in the decrease of mean RR interval, as well as the decrease 
of indices of the standard deviation of beat-to-beat intervals (SDNN), low frequency content 
(LF), and also non-linear indices VAI and VLI [17]. Moreover, the increased parasympathetic 
activity has been proven to be a the major contributor to the increase in the index for high 
frequency (HF) content [18]. HRV analysis has also given an insight into understanding the 
abnormalities of CHF, and can also be used to identify the higher-risk CHF patients. 
Depressed HRV has been used as a risk predictor in CHF [9; 11; 19; 20]. CHF patients usually 
have a higher sympathetic and a lower parasympathetic activity [9; 20]. Typical HRV analysis 
for CHF patients include the following publications: Nolan et al. performed a prospective 
study on recruited 433 CHF patients and found that SDNN was the most powerful predictor 
of the risk of death for CHF disease [13]. Binkley et al. studied 15 healthy subjects and 10 
CHF patients, and reported that parasympathetic withdrawal, in addition to the augmentation 
of sympathetic drive, is an integral component of the autonomic imbalance characteristic for 
CHF patients and can be detected noninvasively by HRV spectral analysis [9]. Rovere et al. 
studied 202 CHF patients and reported that the LF component was a powerful predictor of 
sudden death in CHF patients [21]. Hadase et al. also confirmed that the very low frequency 
(VLF) content was a powerful predictor from a 54 CHF patient study [2]. Woo et al. studied 
21 patients with heart failure and demonstrated that Poincare plot analysis is associated with 
marked sympathetic activation for heart failure patients and may provide additional 
prognostic information and an insight into autonomic alterations and sudden cardiac death 
[20]. Guzzetti et al. (2000) studied 200 CHF patients and found significantly lower 
normalized LF power and lower 1/f slope in CHF patients compared with controls. Moreover, 
the patients who died during the follow-up period presented further reduced LF power and 
steeper 1/f slope than the survivors [22]. Makikallio et al. studied 499 CHF patients and 
showed that a short-term fractal scaling exponent was the strongest predictor of mortality of 
CHF [23]. Poon and Merrill studied 8 healthy subjects and 11 CHF patients, and found that 
the short-term variations of beat-to-beat interval exhibited strongly and consistently chaotic 
behaviour in all healthy subjects but were frequently interrupted by periods of seemingly 
non-chaotic fluctuations in patients with CHF [19]. Peng et al. used FDA analysis and 
confirmed a reduction in HR complexity in CHF patients [24]. Liu et al. studied 60 CHF 
patients and 60 healthy control subjects, and reported decrease of ApEn values in CHF group 
[25]. Costa et al. used the multiscale entropy  method for classifying CHF patients and 
healthy subjects, and reported that the best discrimination between CHF and healthy HR 
signals with the scale 5 in the multiscale entropy calculation [26]. 
All those studies have verified that decreased HRV was associated with the increased 
mortality in CHF patients. However, detailed analysis of the power of the indices to 
distinguishing CHF from normal cardiac function is lacking. Existing studies included the 
work of Pecchia et al. that compared a limited number of time-domain and frequency-domain 
indices [27], the work from Mietus et al. comparing the performance of a family of pNNx 
indices, defined as the mean number of times per hour in which the change in consecutive 
normal sinus intervals exceeds x ms, [28], and the work from Isler et al. using a wavelet 
entropy method [7]. However, investigations comparing a wide range of indices is missing. 
Evaluating how well the common HRV indices can separate CHF patients from normal 
subjects could lead to an important clinical tool. This study therefore investigated the 
commonly used short-term HRV indices, subdivided into three groups: time-domain, 
frequency-domain and non-linear, to compare their abilities to differentiate normal sinus 
rhythm (NSR) subjects and CHF patients.  
 
2. Method 
2.1. Data 
RR interval time series data were from a free-access, on-line archive database  in 
http://www.physionet.org [29]. The original ECG signals were digitized at 128 Hz, and the 
beat annotations were obtained by automated analysis with manual review and correction. 
Fifty-two NSR subjects and 18 CHF patients were studied. Two 5-min RR segments from 
every subject/patient, neither of which had any ectopic beat, were analyzed. Figure 1 shows 
the examples of 5-min RR segments from NSR subjects and CHF patients respectively.  
 
Figure 1. (A1-A4) Examples of 5-min RR segments from NSR subjects. (B1-B4) Examples of 
5-min RR segments from CHF patients. 
 
2.2. HRV index calculations 
Time-domain indices. The mean value (MEAN) of RR intervals, the standard deviation 
(SDNN) of RR intervals and the square root of mean squared differences of successive RR 
intervals (RMSSD) were used as time-domain indices [30; 31], defined as: 
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where RRn denotes the nth RR interval.  
Frequency-domain indices. The AR method can be used for the analysis of frequency domain. 
AR method of order p is expressed as the following equation [32]:  
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where a(k) are the AR coefficients and w[n] is white noise of variance equal to σ2. The Burg 
method is used to get the AR model parameter. The power spectrum of a pth order AR process 
is [32]: 
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where Ep is total least square error. 
Burg’s method with an order of 16 was used to produce the HRV frequency spectrum, which 
was integrated across the low-frequency power (0.04 to 0.15 Hz) and high-frequency power 
(0.15 to 0.40 Hz) spectra. The normalized low-frequency power (LFn) and normalized 
high-frequency power (HFn), and their ratio (LF/HF) were used as the frequency-domain 
indices [30].  
Non-linear indices. The vector length index (VLI) and vector angle index (VAI) from 
Poincare scatter plots were studied as two non-linear indices. They are defined by [33]: 
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where, 
il  is the vector length of each point in the Poincare scatter plot of the RR interval 
time series, L is the mean vector length, 
i  is the angle of each point, and N is the point 
number of the Poincare scatter plot. 
Sample entropy (SampEn) was also studied as a non-linear index. The detailed 
calculation can refer to [34]. Because SampEn values are influenced by the parameters of 
embedding dimension m and tolerance threshold r [35], we used the different parameter 
combinations as follows: m was set as 1, 2 and 3 and r set as 0.10, 0.15, 0.20 and 0.25, to 
determine the parameter combination giving the best distinguishing performance for CHF 
patients and NSR subjects. 
Figure 1 also shows the output values of the aforementioned HRV indices, which reports 
similar results between the two groups. 
 
2.3. Statistical analysis 
Normal distributions of all HRV indices for the two groups were confirmed by the 
Kolmogorov-Smirnov test and Q-Q plot. All HRV indices meet the normal distribution. The 
paired differences between the first and second segments for the NSR and CHF group, as well 
as for the first, second and average calculated values for the nine HRV indices. The Student 
t-test was used to test the statistical difference between the two groups for all calculations. All 
statistical analyses were performed using the SPSS software (Ver. 20, IBM, USA). A 
statistical significance was accepted at P<0.05. 
 
2.4. Classification algorithm 
In order to verify the effectiveness of those HRV indices, we used a simple SVM-based 
classification algorithm for classifying the CHF and NSR subjects. As one of the most 
popular classifiers, SVM aims at minimizing an upper bound of the generalization error 
through maximizing the margin between the separating hyperplane and the data, and it has 
been successfully applied to many situations [36]. In this study, 10-fold cross-validation 
method was used for training and testing of SVM. The smaller the 10-fold cross-validation 
error, the better the classification effect. There are totally 52×3 5-min RR segments from NSR 
group and 18×3 5-min RR segments from CHF group. The 5-min RR segments were 
randomly divided into 10 folds. The division was performed separately for the two groups to 
keep each fold has similar amount 5-min RR segments for both two groups. Then the SVM 
was trained using the HRV index results on the nine folds and was tested on the remaining 
one fold. The indices of Se, Sp and Acc were calculated to evaluate the SVM model.  
 3. Results 
First, we tested the group difference results (mean ± standard error of mean SEM) 
between the NSR and CHF groups when using SampEn index under different parameter 
combinations as described in the Methods section. Table 1 shows the lower and upper bounds 
of normalized 95% confidence interval (CI) of mean group difference of SampEn values by 
averaging the results from the two 5-min segments. The parameter combination of embedding 
dimension m=1 and tolerance threshold r=0.10 reported the best distinguishing performance 
for CHF patients and NSR subjects. Thus this parameter combination was used in the 
following analysis. 
Table 1. Lower and upper bounds of normalized 95% CI of mean group difference for 
SampEn index when using different parameter combinations of m and r. * means P<0.05. 
 
Parameter value Normalized mean 
group difference 
Normalized 95% CI of mean group 
difference 
P value 
between two 
groups r m Lower Upper 
0.10 1 1 0.25 1.75 0.010* 
 2 1 0.10 1.90 0.030* 
 3 1 -1.86 3.86 0.488 
0.15 1 1 -0.69 2.69 0.243 
 2 1 -1.03 3.03 0.331 
 3 1 -9.33 11.33 0.847 
0.20 1 1 -1.81 3.81 0.481 
 2 1 -1.67 3.67 0.459 
 3 1 -1.78 3.78 0.475 
0.25 1 1 -0.88 2.88 0.293 
 2 1 -0.75 2.75 0.259 
 3 1 -0.59 2.59 0.215 
 
Table 2 shows the paired difference results (mean ± SEM) of all HRV indices between 
the first and second segments for the NSR and CHF groups separately, and for all subjects 
combined. The lower and upper boundaries of 95% CI of segment difference are also show. 
Table 2 shows that there was no significant difference between the two 5-min RR interval 
segments for any technique (all P>0.05) in both NSR and CHF groups, and in all subjects 
combined.  
 
Table 2. Statistical results for paired differences of the first and second segments. 
Grou
p 
Type Indices Segment 
difference ± 
SEM 
95% CI of segment 
difference 
P value between 
two segments 
 Lower Upper 
NSR Time-domain MEAN (ms) -5.12 ± 9.02 -23.23 12.98 0.57 
SDNN (ms) 0.84 ± 2.81 -4.80 6.48 0.77 
RMSSD (ms) 1.64 ± 1.58 -1.53 4.81 0.30 
Frequency-domain LFn -0.006 ± 0.02 -0.05 0.03 0.76 
HFn 0.006 ± 0.02 -0.03 0.05 0.76 
LF/HF -0.17 ± 0.42 -1.02 0.67 0.68 
Nonlinear  VAI 0.02 ±0.02 -0.02 0.07 0.37 
VLI 1.06 ± 3.56 -6.10 8.21 0.77 
SampEn 0.02 ± 0.05 -0.07 0.11 0.681 
CHF Time-domain MEAN (ms) -0.66 ± 6.48 -14.32 13.00 0.92 
SDNN (ms) 1.64 ± 3.03 -4.74 8.03 0.59 
RMSSD (ms) 0.12 ± 5.58 -11.66 11.90 0.98 
Frequency-domain LFn 0.02 ± 0.04 -0.07 0.12 0.58 
HFn -0.02 ± 0.04 -0.12 0.07 0.58 
LF/HF -0.11 ± 0.38 -0.92 0.69 0.77 
Nonlinear  VAI -0.05 ± 0.05 -0.16 0.05 0.32 
VLI 2.92 ± 2.04 -1.38 7.22 0.17 
SampEn -0.03 ± 0.04 -0.12 0.06 0.53 
All Time-domain MEAN (ms) -3.98 ± 6.88 -17.71 9.76 0.57 
SDNN (ms) 1.05 ±2.22 -3.37 5.47 0.64 
RMSSD (ms) 1.25 ± 1.83 -2.40 4.90 0.50 
Frequency-domain LFn 0.002 ± 0.02 -0.04 0.04 0.93 
HFn -0.002 ± 0.02 -0.04 0.04 0.93 
LF/HF -0.16 ± 0.33 -0.81 0.49 0.63 
Nonlinear VAI 0.002 ± 0.02 -0.04 0.04 0.92 
VLI 1.53 ± 2.69 -3.84 6.91 0.57 
SampEn 0.004 ± 0.04 -0.06 0.08 0.85 
 
Table 3 shows the group difference results (mean ± SEM) of all HRV indices between 
the NSR and CHF groups. Table 3 shows that the group differences between the NSR and 
CHF groups were similar when comparing the results from the first and second 5-min RR 
segments, as well as from the average of the two 5-min segments. For the average segment 
results, all frequency-domain and non-linear indices, but only one time-domain index 
(SDNN), showed significant differences (all P<0.05) between NSR and CHF groups. The best 
performing techniques were VLI (P=0.001) and SDNN (P=0.003), followed by all three 
frequency indices LFn, HFn and LF/HF (all P=0.006), VAI (P=0.009) and SampEn (P=0.010). 
Figure 2 shows the lower and upper boundaries of normalized (mean group difference 
equals to 1) 95% CI of mean group difference for nine HRV indices, ordered for increasing 
discrimination power (top to bottom) for the average results of the two 5-min RR interval 
segments. The lower confidence interval is shown on the right with an expended scale, where 
results for RMSSD are off scale and not shown. When the lower boundary of the normalized 
CI lies above zero this indicates statistical significance with P value given in Table 3. For the 
average of the two segments, it shows the order of HRV indices for discriminating NSR and 
CHF groups was in the following order: VLI, SDNN, LFn & HFn & LF/HF, VAI, SampEn, 
with Mean abs RMSSD indicating no significant discriminating power. 
 
Table 3. Statistical results for group differences between NSR and CHF groups. * means 
P<0.05 and ** means P<0.01. 
Signal Type Indices NSR CHF P value 
First 5-min segment Time-domain  MEAN (ms) 707± 16 669± 16 0.109 
SDNN (ms) 42± 3  28± 5 0.016* 
RMSSD (ms) 22 ± 2 19± 5 0.456 
Frequency-domain LFn 0.73 ± 0.03 0.56± 0.06 0.003** 
HFn 0.27 ± 0.03 0.44± 0.06 0.003** 
LF/HF 4.67 ± 0.46 2.34± 0.60 0.009** 
Nonlinear  VAI (º) 0.63 ± 0.03 0.45 ± 0.04 0.005** 
VLI (ms) 46 ± 4 28 ± 4 0.002** 
SampEn  1.87± 0.05 1.61± 0.07 0.012* 
Second 5-min segment Time-domain  MEAN (ms) 712± 17 670± 15 0.068 
SDNN (ms) 41± 3  26± 4 0.003** 
RMSSD (ms) 20 ± 1 18± 3 0.621 
Frequency-domain LFn 0.74 ± 0.03 0.54± 0.07 0.009** 
HFn 0.26 ± 0.03 0.46± 0.07 0.009** 
LF/HF 4.84 ± 0.52 2.45± 0.60 0.014* 
Nonlinear  VAI (º) 0.61 ± 0.03 0.50 ± 0.06 0.057 
VLI (ms) 45 ± 3 25 ± 4 0.001** 
SampEn 1.85± 0.05 1.64± 0.08 0.028* 
Average of the two 5-min 
segments 
Time-domain  MEAN (ms) 710± 16 670± 15 0.078 
SDNN (ms) 42± 2  27± 4 0.003** 
RMSSD (ms) 21 ± 1 19± 4 0.509 
Frequency-domain LFn 0.74 ± 0.02 0.55± 0.06 0.006** 
HFn 0.26 ± 0.02 0.45± 0.06 0.006** 
LF/HF 4.75 ± 0.44 2.40± 0.57 0.006** 
Nonlinear  VAI (º) 0.62 ± 0.03 0.47 ± 0.04 0.009** 
VLI (ms) 46 ± 3 27 ± 4 0.001** 
SampEn 1.86± 0.05 1.62± 0.07 0.010* 
 
 
Figure 2. Lower and upper boundaries of normalized (mean group difference equals 1) 95% 
CI of mean group difference for all nine HRV indices. The axis scale for the lower CI 
boundary is expanded on the right to better illustrate differences. 
Table 4 shows the 10-fold cross validation of SVM classifier results on all 210 5-min RR 
segments used in this study. The mean 𝑆𝑒, 𝑆𝑝 and 𝐴𝑐𝑐 of SVM classifier from 10 folds are 
91.31%, 90.04% and 90.95% respectively. The SD values of 𝑆𝑒, 𝑆𝑝 and 𝐴𝑐𝑐 indices are 
11.75%, 6.19% and 4.74% respectively. 
 
Table 4. Results of 10-fold cross validation for classifying NSR and CHF groups using the 
default SVM parameter setting. 
Fold MSE_RR (original RR segment) 
𝑆𝑒 (%) 𝑆𝑝 (%) 𝐴𝑐𝑐 (%) 
1 75 94.12 90.48 
2 83.33 93.33 90.48 
3 83.33 93.33 90.48 
4 100 100 100 
5 100 85.71 90.48 
6 100 94.12 95.24 
7 100 94.44 95.24 
8 71.43 92.86 85.71 
9 100 81.25 85.71 
10 100 81.25 85.71 
Mean 91.31 90.04 90.95 
SD 11.75 6.19 4.74 
 
4. Discussion 
Previous studies have shown that HRV indices can predict of CHF incidents. Nolan et al. 
found that SDNN was a predictor of the death risk for CHF disease [13]. Rovere et al. 
reported that the LF component was a predictor of sudden death in CHF patients [37]. Hadase 
et al. also confirmed that VLF was a predictor [2]. All those studies verified that the decreased 
HRV was associated with increased mortality in CHF patients. For discriminating CHF 
patients from normal subjects, Pecchia et al. designed a classifier based on the regression tree 
method and selected RMSSD, total power, HF, and LF/HF as useful classification features 
[27]. Previous studies have also described two abnormal Poincare plot patterns in CHF 
patients: a torpedo pattern with reduced beat to beat variability and a complex pattern with 
clustering of points [20]. Isler et al. designed a 7-nearest neighbor classifier, and found that 
the best subset of classification features were MEAN, RMSSD, VLI, LF/HF, VLF (0 to 0.04 
Hz), LFn and HFn [7]. Liu et al. proposed three nonstandard HRV measures. With the 
combination of SVM, they reported a perfect CHF classification accuracy, sensitivity and 
specificity of 100%, 100%, 100%, respectively [38]. Kazmi et al. used human and animal 
data to demonstrate the inverse correlation between HRV and HR, and thus to suggest the 
common NSR/CHF classification using HRV method should considering the HR effect [39].  
In this study, we found that all frequency-domain and nonlinear indices, as well as 
time-domain index SDNN, had discrimination power for CHF patients and NSR subjects.  
Importantly, we compared the discrimination power of the common HRV indices and found 
that some indices were much more sensitive to the clinical differences than others, with the 
best performing techniques VLI and SDNN, followed by all three frequency indices LFn, HFn 
and LF/HF, and non-linear index SampEn. We have shown that some analysis techniques are 
much more effective in separating the two clinical groups than others, providing both useful 
analysis tools and suggesting possible differences between the rhythms. For performance 
validation of the employed HRV indices, we performed a classification method using the 
common SVM toolbox and achieved a classification accuracy of 90.95% when using 10-fold 
cross validation on the MIT-BIH NSR and CHF RR interval databases. 
ANS has sympathetic and parasympathetic components. Sympathetic stimulation causes 
an increase in HR by increasing the firing rate of pacemaker cells in the heart’s sino-atrial 
node. Parasympathetic activity decreases the firing rate of pacemaker cells and the HR. 
Sympathetic activity is associated with the low frequency range (0.04-0.15 Hz) while 
parasympathetic activity is associated with the higher frequency range (0.15-0.4 Hz) of 
modulation frequencies of the HR [32]. Reference [40] demonstrated that the activation of the 
sympathetic nervous system, the decreased activity of the parasympathetic nervous system, as 
well as the depressed baroreceptor function, are early features that may precede the onset of 
clinically obvious symptoms and signs of heart failure. The difference between the two 
groups can be partly explained by the ANS balance. The CHF patients usually have a lower 
parasympathetic activity and a higher sympathetic activity [8; 9; 20; 41]. Decreased 
parasympathetic and increased sympathetic activity results in the decrease of mean RR 
interval, as well as the decreases of indices of SDNN [32], LFn [30; 42], VAI and VLI [17], 
whereas increased parasympathetic activity is the major contributor to the increase of index of 
HFn [18; 42; 43].  
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